OFIX

Orthofix Medical Inc. (OFIX) ESG Analysis Analysis (2026)

Invetso Score: 5/10 — Balanced · Last Updated: 2026-08-01

Overall Score

Environmental

No material environmental disclosures or sustainability metrics were provided this month.

Capital intensity remains manageable, with capex at 5.3% of revenue and capex/depreciation at 0.34x, suggesting limited near-term environmental reinvestment pressure.

Social

No material social or workforce-related disclosures or news were provided this month.

SG&A remains elevated at 50.3% of revenue, which may indicate ongoing operating complexity but is not a direct social disclosure.

Governance

No material governance disclosures or board/ownership updates were provided this month.

Balance-sheet leverage remains moderate, with net debt to EBITDA at 1.22x and a current ratio of 2.84x, supporting financial flexibility.

Risk

No material ESG-related controversies, regulatory actions, or litigation were reported this month.

Weak profitability and cash generation remain a concern, with negative ROA (-7.1%), ROE (-14.1%), and free cash flow yield (-6.5%).

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Orthofix Medical Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →